SCHEMBL24247

SCHEMBL24247

C1=CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2208868 1.00
Water SCHEMBL28030242 0.96
Hydrochloric Acid SCHEMBL30449038 0.96
Lithium SCHEMBL29434589 0.96
SCHEMBL19874577 0.96
Hydrochloric Acid SCHEMBL3253492 0.96
SCHEMBL28736431 0.96
Ethane SCHEMBL27979426 0.93
SCHEMBL7003933 0.90
SCHEMBL17102125 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9456 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105216-B1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2026-05-20 EP claimed
US-12622905-B2 Aryl pladienolides for the treatment of neoplastic disorders EISAI R&D MANAGEMENT CO., LTD. (JP) 2026-05-12 US claimed
US-20260109702-A1 NOVEL GSPT PROTEIN DEGRADER AND APPLICATION THEREOF GENOSCO INC (US) 2026-04-23 US claimed
EP-3806853-B1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES ONCO3R THERAPEUTICS BV (BE) 2026-03-18 EP claimed
EP-4266445-B1 SULFUR-BASED BORON TRIFLUORIDE SALT ELECTROLYTE CONTAINING UNSATURATED HETEROCYCLE, PREPARATION METHOD THEREFOR AND USE THEREOF BEIJING WELION NEW ENERGY TECH CO LTD (CN) 2026-01-07 EP claimed
WO-2025215558-A1 COMPOUNDS FOR SPLICING MODULATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-10-16 WO claimed
CN-111655695-B Substituted furopyrimidine compounds as PDE1 inhibitors 达特神经科学有限公司 2025-05-27 CN claimed
CN-119859140-A Liquid crystal molecule, preparation method and application 中国石油化工股份有限公司 2025-04-22 CN claimed
WO-2025032214-A1 INDAZOLE COMPOUNDS AND AZAINDAZOLE COMPOUNDS AS INHIBITORS OF RAF KINASES PIERRE FABRE MEDICAMENT (FR) 2025-02-13 WO claimed
WO-2025010311-A1 UREA-CONTAINING AGONISTS OF OREXIN RECEPTOR TYPE 2 VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-01-09 WO claimed
EP-0004727-B1 BLOOD PLATELET AGGREGATION INHIBITORY PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND PROCESSES FOR THEIR MANUFACTURE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1981-08-12 EP claimed
EP-0004726-B1 BLOOD PLATELET AGGREGATION INHIBITORY TETRAHYDROPYRIDINE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS THEREOF AND PROCESSES FOR ITS MANUFACTURE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1981-01-28 EP claimed
US-4208325-A Preparation of 1-oxapenicillins and 4-acyloxy azetidinone intermediates therefor QUEEN'S UNIVERSITY AT KINGSTON (CA) 1980-06-17 US claimed
EP-0004727-A2 Blood platelet aggregation inhibitory pyridine derivatives, pharmaceutical compositions thereof, and processes for their manufacture IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-10-17 EP claimed
EP-0004726-A1 Blood platelet aggregation inhibitory tetrahydropyridine derivative, pharmaceutical compositions thereof and processes for its manufacture IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-10-17 EP claimed
US-4166853-A Antihypertensive 7-trifluoromethyl-4-aminoquinolones THE UPJOHN COMPANY (US) 1979-09-04 US claimed
EP-0000106-A1 2-Alkyl nicotinoids and processes for their production and use PHILIP MORRIS INCORPORATED (US) 1978-12-20 EP claimed
US-4113951-A ANTIARRHYTHMIA DELALANDE S. A. (FR) 1978-09-12 US claimed
US-4021400-A SECONDARY AMINES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-05-03 US claimed
US-4018782-A 1-OXAPENICILLINS, ANTIBIOTICS QUEEN'S UNIVERSITY (CA) 1977-04-19 US claimed